Follow-On Biologics Bill IP Provisions Are “Unfavorable” – Wyeth Attorney

The follow-on biologics bill recently unveiled by Rep. Henry Waxman (D-Calif.) and Sen. Chuck Schumer (D-N.Y.) would create an "unfavorable" intellectual property environment for innovators, Wyeth Senior Regulatory Attorney Cecilia Burke suggests